Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| ABBV | AbbVie, Inc. | -0.96% | 92.13 | 1.9% | $1192.97m | |
| JNJ | Johnson & Johnson | -0.87% | 144.44 | 0.7% | $1057.09m | |
| BMY | Bristol-Myers Squibb Co. | -0.57% | 60.79 | 1.0% | $967.46m | |
| PFE | Pfizer Inc. | 0.64% | 37.50 | 0.9% | $831.88m | |
| MRK | Merck & Co., Inc. | -0.22% | 76.38 | 0.7% | $796.50m | |
| LLY | Eli Lilly & Co. | -0.69% | 151.23 | 1.1% | $417.06m | |
| AZN | AstraZeneca Plc | -0.11% | 55.22 | 1.2% | $261.94m | |
| NVS | Novartis AG | -0.09% | 84.91 | 0.2% | $156.50m | |
| GSK | GlaxoSmithKline Plc | -0.37% | 40.88 | 0.2% | $140.53m | |
| NVO | Novo Nordisk A/S | 0.05% | 64.85 | 0.1% | $87.00m | |
| SNY | Sanofi | -0.30% | 47.30 | 0.2% | $78.78m | |
| RGEN | Repligen Corp. | -0.57% | 139.51 | 7.1% | $73.05m | |
| ARCT | Arcturus Therapeutics Holdings, Inc. | 7.71% | 58.27 | 0.0% | $60.48m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 11.80% | 58.37 | 0.0% | $42.40m | |
| RETA | Reata Pharmaceuticals, Inc. | 1.04% | 160.00 | 3.4% | $38.83m |
Company Profile
Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.